Maven Investment Partners US
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 19, 2022
Ventyx Biosciences
|
Post-IPO Equity | $176.60M | Biopharma | — |
Jan 6, 2021
Aileron Therapeutics
|
Post-IPO Secondary | $35.90M | Biopharma | — |
Dec 15, 2020
Kineta (Reverse Merger With Yumanity Therapeutics)
|
Series Unknown | $33.59M | Biotechnology | — |
Nov 25, 2020
MedAvail
|
Series E | $96.99M | Biotechnology | — |
Jul 17, 2020
Frequency Therapeutics
|
Post-IPO Equity | $42.30M | Biotechnology | — |
Maven Investment Partners US has had 5 exits. Maven Investment Partners US most notable exits include Ventyx Biosciences , Kineta (Reverse Merger With Yumanity Therapeutics)
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 21, 2021 | Ventyx Biosciences | IPO | Biopharma | Detail |
Dec 23, 2020 | Kineta (Reverse Merger With Yumanity Therapeutics) | M&A | Biotechnology | Detail |
Nov 8, 2020 | MedAvail | IPO | Biotechnology | Detail |
Oct 2, 2019 | Frequency Therapeutics | IPO | Biotechnology | Detail |
Jun 29, 2017 | Aileron Therapeutics | IPO | Biopharma | Detail |